The healthcare landscape for diabetes is evolving, and transdermal GLP-1 delivery systems represent a exciting breakthrough. Unlike subcutaneous injections, this technique offers a simpler way to provide GLP-1 drugs. These devices slowly release the treatment through the skin offering a even level of the beneficial agent, which can improve glucose